Law360
Assessing FDA Pathways For Genome-Edited Plant Foods
March 21, 2024
In February, the U.S. Food and Drug Administration clarified the regulatory pathway for foods produced from genome-edited plants in the form of a final guidance issued by the agency's Center for Food Safety and Applied Nutrition and Center for Veterinary Medicine, titled "Foods Derived from Plants Produced Using Genome Editing." In this article, Sidley analyzes the paths forward that are available.
Contacts
Capabilities
Suggested News & Insights
Sidley's 2026 San Diego Clinical Trial SeriesThursday, January 29, 2026 | Thursday, March 12, 2026 | Tuesday, April 21, 2026U.S. Clinical Trial Design & Execution RisksThursday, January 29, 2026At the Table: Serving Up a Lively Discussion With the FDA and USDAWednesday, January 28, 2026Medical Products Market Access: Favorable Advisory Opinion Reaffirms Discounting FlexibilitiesJanuary 21, 2026FY 2025 FCA Settlements and Judgments Statistics Show Highest Recoveries EverJanuary 20, 2026Sidley Ranked in Chambers Greater China Region 2026January 15, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

